Author

Prakash Khetan

Observed name: P., Khetan

Observed institutions: Kempegowda Institute of Medical Sciences, Jaslok Hospital

OpenAlex ID: A5031281958

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

2023 · Katherine R Tuttle, Sibylle J Hauske, et al. · The Lancet · 219

Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)

2022 · Sishir Gang, Prakash Khetan, et al. · American Journal of Nephrology · 60

International Study on Sagliker Syndrome and Uglifying Human Face Appearence in Severe and Late Secondary Hyperparathyroidism in Chronic Kidney Disease Patients

2007 · Yahya Sagliker, Vidya Acharya, et al. · Journal of Renal Nutrition · 26

Is survival enough for quality of life in Sagliker Syndrome-uglifying human face appearances in chronic kidney disease?

2008 · Yahya Sagliker, Vidya Acharya, et al. · Journal of Nephrology · 19

An uncommon cause of rapidly progressive renal failure in a lupus patient: Pauci-immune crescentic glomerulonephritis

2018 · ManishR Balwani, Charulata Bawankule, et al. · Saudi Journal of Kidney Diseases and Transplantation · 16

Management Strategies and Outcomes in Renal Transplant Recipients Recovering from COVID-19: A Retrospective, Multicentre Study

2022 · Vivek B. Kute, Deepak S. Ray, et al. · EClinicalMedicine · 10

Awareness about kidney and its related function/dysfunction in school going children: A survey from the Central India

2019 · ManishR Balwani, CharulataP Bawankule, et al. · Saudi Journal of Kidney Diseases and Transplantation · 8

Tacrolimus-induced pure red cell aplasia in a postrenal transplant patient

2019 · Prakash Khetan, Sumeet Jaiswal, et al. · Indian Journal of Transplantation · 2

Wcn26-390 a Phase-4, 52-week, Single Arm, Post-marketing Surveillance to Evaluate Safety of Desidustat for Treatment of Anemia in Subjects With Chronic Kidney Disease

2026 · Prakash Khetan, Hardik Shah, et al. · Kidney International Reports

#3408 Desidustat in CKD anemia: a single center experience

2025 · Prakash Khetan, Seema Khetan · Nephrology Dialysis Transplantation

Phase 4, 52-Week, Single-Arm, Post-Marketing Surveillance to Evaluate Safety of Desidustat for Treatment of Anemia in Patients with CKD

2025 · Kevinkumar Ashokbhai Kansagra, Deven Parmar, et al. · Journal of the American Society of Nephrology

Spontaneous subcapsular renal hematoma in a patient with pauci-immune glomerulonephritis

2022 · Vishal Ramteke, Prakash Khetan, et al. · Journal of The Nephrology Society

Supplementary Material for: Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)

2022 · S., Gang, P., Khetan, et al. · Figshare

Clinical profile and outcome of coronavirus disease 2019-associated acute kidney injury: An observational study from central India

2022 · Vishal Ramteke, TalakonukulaVamshi Krishna, et al. · Journal of The Nephrology Society

Hemolytic uremic syndrome associated with rhabdomyolysis – Need to look beyond kidneys in hemolytic uremic syndrome

2021 · Abhijit Choudhary, T Sneha, et al. · Tropical Doctor

Abdominal Pain and Fever in an Elderly Patient with Diabetes Mellitus

2020 · Prakash Khetan, Vishal Ramteke, et al. · Kidney360

Works count: 16

Citation count: 360

H-index: 7

I10-index: 6